Abstract
Chronic kidney disease (CKD) is prevalent in Central America and ancestry-specific factors may contribute to CKD risk. To understand the genetic ancestry influences on CKD susceptibility, we conducted an admixture mapping of CKD traits and risk factors on 1,023 participants of the Hispanic Community Health Study/Study of Latinos who reported four-grandparents originating from the same Central America country. Admixture mapping signals were validated on 8,191 African Americans from the Women’s Health Initiative, 3,141 American Indians from the Strong Heart Study and 197,272 White individuals from the Million Veterans Program. We identified five novel ancestry-derived loci on chromosomes: 14 for albuminuria; 2, 6 and 9 for CKD; and 3 for type 2 diabetes (T2D). The 14q24.2 locus was validated in American Indians and consisted of two regions spanning the RGS6 gene, in which the European (risk) and Native American (protective) ancestries had opposite effects for albuminuria. This locus was also identified using the traditional association mapping. Among the three CKD loci, the 6q25.3 African ancestry-derived locus at ARID1B gene, associated with increased risk for CKD, was validated in African Americans. The T2D locus at 3q22.2 encompasses the EPHB1 and KY genes and was validated in White individuals. U.S. Hispanic/Latino populations are culturally and genetically diverse. Our strategy of using grandparent country-of-origin for selection of a more genetically similar group likely helped the gene discovery. This study of CKD traits and risk factors in individuals from Central America country-of-origin provides new insights into the ancestry-of-origin influences on CKD in this population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The baseline examination of HCHS/SOL was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contributed to the first phase of HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. The Genetic Analysis Center at Washington University was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). Genotyping efforts were supported by NHLBI HSN 26220/20054C, NCATS CTSI grant UL1TR000124, and NIDDK Diabetes Research Center (DRC) grant DK063491. This study is supported by the following grants: National Institutes of Health MD012765, HL140385 and DK117445 to N. Franceschini.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) data supporting the findings of this study is openly available in the dbGap repository at https://www.ncbi.nlm.nih.gov/gap/, under the accession numbers phs000880.v1.p1 and phs000810.v1.p1. This project used existing genotype and phenotype data from the Women's Health Initiative, which is available through the dbGap (phs000200.v12.p3). The MVP summary statistics is available through dbgap (phs001672.v7.p1).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵** noraf{at}unc.edu
Data Availability
The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) data supporting the findings of this study is openly available in the dbGap repository at https://www.ncbi.nlm.nih.gov/gap/, under the accession numbers phs000880.v1.p1 and phs000810.v1.p1. The admixture mapping linear and logistic mixed models are implemented in the GENESIS R package freely available at http://bioconductor.org/packages/release/bioc/html/ GENESIS.html. This project used existing genotype and phenotype data from the Women's Health Initiative, which is available through the dbGap (phs000200.v12.p3). The MVP summary statistics is available through dbgap (phs001672.v7.p1).